Login / Signup
Impact of BMI and Body Composition on First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma.
Takafumi Yamamoto
Takanori Ito
Kazuyuki Mizuno
Shinya Yokoyama
Kenta Yamamoto
Norihiro Imai
Yoji Ishizu
Takashi Honda
Hiroki Kawashima
Published in:
Anticancer research (2024)
Following systemic treatment for uHCC, patients with low BMI have a poor prognosis. Among anthropometric factors, low SMI is associated with poor OS. In the LEN treatment group, low VATI may impact PFS negatively.
Keyphrases
</>
body composition
poor prognosis
long non coding rna
body mass index
resistance training
combination therapy
radiation therapy
weight gain
rectal cancer
locally advanced
drug induced